LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Home・Aandelen Lijst・Schrodinger Inc

Schrodinger Inc

Open

SectorGezondheidszorg

13.31 0.76

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

13.22

Max

13.39

Belangrijke statistieken
By Trading Economics
Inkomsten	-196M -60M
Verkoop	-29M 59M
EPS	-0.621
Winstmarge	-102.456
Werknemers	850
EBITDA	-85M -49M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+41.35% upside

Dividenden
By Dow Jones
Volgende Winsten	5 aug 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-64M 900M
Vorige openingsprijs	12.55
Vorige sluitingsprijs	13.31

Nieuwssentiment

By Acuity

100%

326 / 345 Rangschikking in Healthcare

Schrodinger Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 mei 2026, 23:46 UTC

Marktinformatie

Pullback in Oil Prices Could Temper Inflation Expectations -- Market Talk

24 mei 2026, 23:45 UTC

Marktinformatie

Gold, Silver Rise on Hopes for U.S.-Iran Deal -- Market Talk

24 mei 2026, 23:42 UTC

Marktinformatie

Mineral Resources Bull More Positive Post Site Visit -- Market Talk

24 mei 2026, 23:34 UTC

Marktinformatie

Oil Falls Amid Prospects for Reopening of Strait of Hormuz -- Market Talk

24 mei 2026, 23:11 UTC

Marktinformatie

RBNZ Likely to Stand Pat But Watch for Dissent -- Market Talk

24 mei 2026, 22:26 UTC

Acquisities, Fusies, Overnames

Beach Energy: La Bella 2 Will No Longer Be Drilled as Part of Equinox Campaign

24 mei 2026, 22:25 UTC

Acquisities, Fusies, Overnames

Beach Energy: Implied Transaction Value of Around A$130 Million After Tax

24 mei 2026, 22:25 UTC

Acquisities, Fusies, Overnames

Beach Energy: Royalty Payments Likely to Total Around A$140 Million Based on Resource Booking

24 mei 2026, 22:24 UTC

Acquisities, Fusies, Overnames

Beach Energy to Get Production Royalty of A$3.75/GJ in Deal

24 mei 2026, 22:24 UTC

Acquisities, Fusies, Overnames

Beach Energy to Get A$70 Million Cash Proceeds When Deal Completes

24 mei 2026, 22:23 UTC

Acquisities, Fusies, Overnames

Beach Energy Says Deal Includes Artisan Natural-Gas Discovery

24 mei 2026, 22:23 UTC

Acquisities, Fusies, Overnames

Beach Energy Sells 60% Operated Interest in VIC/L35 Block in Otway Basin

24 mei 2026, 22:11 UTC

Marktinformatie

Oil Price Unlikely to Return to Pre-Conflict Levels This Year -- Market Talk

24 mei 2026, 22:04 UTC

Marktinformatie

Oil Price Likely Lower, Equities Higher on Iran Deal Talks Progress -- Market Talk

23 mei 2026, 08:20 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Financial Services Roundup: Market Talk

23 mei 2026, 08:20 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

22 mei 2026, 21:10 UTC

Winsten

These Stocks Are Today's Movers: Dell, Apple, IBM, Estée Lauder, Futu, Rocket Lab, Workday, and More -- Barrons.com

22 mei 2026, 20:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

22 mei 2026, 20:50 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Financial Services Roundup: Market Talk

22 mei 2026, 20:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

22 mei 2026, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

22 mei 2026, 19:47 UTC

Winsten

Nvidia Has a Plan to Get the Stock Moving Again -- Barrons.com

22 mei 2026, 19:17 UTC

Marktinformatie

U.S. Natural Gas Retreats As Weather Outlook Cools -- Market Talk

22 mei 2026, 19:10 UTC

Marktinformatie

Oil Futures Edge Up Ahead of U.S. Long Weekend -- Market Talk

22 mei 2026, 18:54 UTC

Marktinformatie

Global Equities Roundup: Market Talk

22 mei 2026, 18:54 UTC

Marktinformatie

Kroger Seen Narrowing Pricing Gap Versus Walmart -- Market Talk

22 mei 2026, 18:38 UTC

Marktinformatie

Canada's Population Slowdown Hits Demand for Consumer Companies -- Market Talk

22 mei 2026, 18:35 UTC

Acquisities, Fusies, Overnames

IMAX Might Be Exploring a Sale. Who Could Be Buying. -- Barrons.com

22 mei 2026, 18:09 UTC

Marktinformatie

Centralized Crypto Lending Slows in 1Q -- Market Talk

22 mei 2026, 17:58 UTC

Marktinformatie

U.S. Oil Rig Count Shows Signs of Picking Up -- Market Talk

Peer Vergelijking

Prijswijziging

Schrodinger Inc Prognose

Koersdoel

By TipRanks

41.35% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 18.8 USD 41.35%

Hoogste 24 USD

Laagste 13 USD

Gebaseerd op 7 Wall Street-analisten die 12-maands prijsdoelen bieden voor Schrodinger Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

7 ratings

Buy

Hold

Sell

Gebaseerd op 7 analisten die aandelenratings hebben gegeven aan Schrodinger Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

326 / 345 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.